You have 8 free searches left this month | for more free features.

≥6 years

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Evaluate Speech and Language Development in Chinese Children

Not yet recruiting
  • Mental Retardation
  • +2 more
  • establish a new Chinese children's speech and language norm
  • (no location specified)
Jun 28, 2022

Reading Trial in Copenhagen (Teaching involving whole-body movements, Teaching involving hand movements, Teaching involving

Completed
  • Reading
  • Teaching involving whole-body movements
  • +2 more
  • Copenhagen, Denmark
    University of Copenhagen
Nov 7, 2022

Measles; Mumps; Rubella; Chickenpox Trial in United States (Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS

Recruiting
  • Measles; Mumps; Rubella; Chickenpox
  • Investigational MMRV(H)NS vaccine
  • +3 more
  • Jonesboro, Arkansas
  • +9 more
Jan 16, 2023

Cleft Palate Technique and Maxillary Growth

Recruiting
  • Cleft Palate
  • Growth
  • 2 flap palatoplasty technique
  • +2 more
  • Fayoum, Egypt
    Fayoum University
Jan 27, 2023

Body Image, Anti Fat Bias Trial in Bristol (Positive body image TV show, Positive body image music video, Active control TV show

Recruiting
  • Body Image
  • Anti Fat Bias
  • Positive body image TV show
  • +3 more
  • Bristol, United Kingdom
    Centre for Appearance Research, UWE
Nov 21, 2023

Type 1 Diabetes Trial in Helsinki (Medronic 780G insulin pump)

Recruiting
  • Type 1 Diabetes
  • Medronic 780G insulin pump
  • Helsinki, Finland
    Helsinki University Hospital, New Children's Hospital and Jorvi
Jan 10, 2022

Respiratory Syncytial Virus Trial in Worldwide (Nasal swab sampling, Blood sampling, Diary cards)

Completed
  • Respiratory Syncytial Virus
  • Nasal swab sampling
  • +2 more
  • Oakland, California
  • +22 more
Nov 2, 2022

Lymphatic Malformation Trial (TARA-002)

Not yet recruiting
  • Lymphatic Malformation
  • TARA-002
  • (no location specified)
May 22, 2023

Outcome of PAS in Two Large Referral Hospitals in Egypt

Active, not recruiting
  • Placenta Accreta
    • Cairo, Egypt
      Kasr Alainy , Cairo University
    Nov 24, 2022

    Atopic Dermatitis, Eczema Trial (Lebrikizumab, Placebo)

    Not yet recruiting
    • Atopic Dermatitis
    • Eczema
    • (no location specified)
    Feb 10, 2023

    Obesity, Childhood Trial in Minneapolis (Lisdexamfetamine Dimesylate, Lifestyle therapy)

    Not yet recruiting
    • Obesity, Childhood
    • Lisdexamfetamine Dimesylate
    • Lifestyle therapy
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 1, 2022

    Puberty, Precocious, Breast, Environmental Exposure Trial in Lambersart, Lille (Environmental health measures)

    Recruiting
    • Puberty, Precocious
    • +2 more
    • Environmental health measures
    • Lambersart, Nord Pas De Calais, France
    • +1 more
    Oct 11, 2023

    Nonsene Mutation Duchenne Muscular Dystrophy Trial in Atlanta (Ataluren)

    Recruiting
    • Nonsene Mutation Duchenne Muscular Dystrophy
    • Atlanta, Georgia
      Rare Disease Research, LLC
    Jan 27, 2023

    Traveler's Diarrhea Trial (Rifamycin SV-MMX, Placebo)

    Not yet recruiting
    • Traveler's Diarrhea
    • Rifamycin SV-MMX
    • Placebo
    • (no location specified)
    Jan 26, 2023

    Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox

    Completed
    • Smallpox
    • +3 more
    • VAC∆6 vaccine (10⁷ PFU)
    • +3 more
    • Koltsovo, Novosibirsk Region, Russian Federation
    • +1 more
    Apr 25, 2023

    Attention Deficit Disorder With Hyperactivity Trial in Las Vegas, Durham (Aptensio XR, Placebo)

    Completed
    • Attention Deficit Disorder With Hyperactivity
    • Aptensio XR
    • Placebo
    • Las Vegas, Nevada
    • +1 more
    Nov 10, 2021

    COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

    Completed
    • COVID-19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
    • Taizhou, Jiangsu, China
      Taixing City center for Disease Control and Prevention
    Oct 28, 2022

    Schistosomiasis Trial in Abidjan, Kisumu (L-PZQ ODT, Biltricide®)

    Completed
    • Schistosomiasis
    • Abidjan, Côte D'Ivoire
    • +1 more
    Oct 13, 2021

    Arthrosis of Hand Trial in Paris (GENETIC and radiographs)

    Active, not recruiting
    • Arthrosis of Hand
    • GENETIC and radiographs
    • Paris, France
      Service de Rhumatologie - Hôpital Saint-Antoine
    Nov 15, 2021

    Emmetropization, Myopia, Hyperopia Trial (DEFOG glasses(peripheral focus-out glasses))

    Not yet recruiting
    • Emmetropization
    • +2 more
    • DEFOG glasses(peripheral focus-out glasses)
    • (no location specified)
    Jan 10, 2023

    Exposure to Organic Dust - Mean Follow up at 6 Years

    Enrolling by invitation
    • COPD
    • Exposure Occupational
    • Pulmonary Function Testing
    • Besançon, France
      CHU de Besançon
    Aug 2, 2021

    Trauma, Psychological, Stress, Psychological, Anxiety Disorders Trial in Nice (EMDR therapy, Routine Care)

    Not yet recruiting
    • Trauma, Psychological
    • +2 more
    • EMDR therapy
    • Routine Care
    • Nice, France
      Hôpitaux Pédiatriques de Nice CHU-Lenval
    Jun 10, 2022

    Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of

    Completed
    • Smallpox
    • +3 more
    • VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
    • +3 more
    • Novosibirsk, Koltsovo, Novosibirsk Region, Russian Federation
      Federal State Budgetary Healthcare Institution - Medical and San
    Feb 28, 2023

    Alopecia Areata Trial (Ritlecitinib 20 mg)

    Not yet recruiting
    • Alopecia Areata
    • Ritlecitinib 20 mg
    • (no location specified)
    Dec 6, 2022

    Healthy Children Trial (Functional training)

    Not yet recruiting
    • Healthy Children
    • Functional training
    • (no location specified)
    Feb 17, 2023